Oral Anticoagulation : Atrial Fibrillation & Percutaneous Coronary Intervention

Journal Club: Clinical Updates in Oral Anticoagulation for Patients With Atrial Fibrillation Requiring Percutaneous Coronary Intervention

Evaluating Treatment Strategies With a Non–Vitamin K Oral Anticoagulant in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Part 1 of 2 from "Journal Club: Clinical Updates in Oral Anticoagulation for Patients With Atrial Fibrillation Requiring Percutaneous Coronary Intervention"

Based on a review of "Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI" (The New England Journal of Medicine. 2016;375:2423-2434).

Content developed in concert with the faculty.
Release Date: 30 January 2017
Expiration Date: 29 July 2018

Learning Objectives

• Review guidelines and data on the use of oral anticoagulation in patients with atrial fibrillation (AF) requiring percutaneous coronary intervention (PCI)
• Summarise recently published data from a study evaluating a non–vitamin K oral anticoagulant (NOAC) for the treatment of patients with AF requiring PCI
• Discuss how these data will impact clinical practice